Cargando…
Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study
Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended globa...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590168/ https://www.ncbi.nlm.nih.gov/pubmed/37868398 http://dx.doi.org/10.7759/cureus.45701 |
_version_ | 1785123943019970560 |
---|---|
author | Novais, Catarina Santos, Joaquim Alves, Claúdia Mendonça, Ema Salgado, João Lopes, Diogo Cruz, Ana Margarida |
author_facet | Novais, Catarina Santos, Joaquim Alves, Claúdia Mendonça, Ema Salgado, João Lopes, Diogo Cruz, Ana Margarida |
author_sort | Novais, Catarina |
collection | PubMed |
description | Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended global clinical decision is to refrain from employing CHC in female smokers aged 35 or older. This study aimed to improve contraception prescription for female smokers aged 35-54 in PC. Methods This study was conducted in a Portuguese Family Health Unit (FHU) from October 2021 to August 2022, and it followed the Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0) guidelines and the Plan-Do-Study-Act approach. Female smokers aged 35-54 were included and evaluated in three moments: baseline evaluation (October 2021), intermediate evaluation (February 2022), and post-intervention evaluation (August 2022). Interventions involved educating medical staff, creating patient awareness campaigns, and evaluating contraceptive methods. The established quality-defining goal was to decrease the prevalence of female smokers aged 35 or above using CHC to ≤5%. Results CHC prevalence among smoking women aged 35-54 decreased from 16.4% to 8.5% after nine months of the initial intervention. There was an increase in progestogen-only methods usage over time, from 25.7% to 34.0%. Discussion Despite not fully achieving the predefined goal, interventions led to a substantial reduction of CHC use among smoking women aged 35-54. Collaborative efforts between healthcare professionals and patients played a pivotal role in optimizing care and reducing cardiovascular risk. This study underscores the importance of continuous quality improvement, collaborative interventions, and knowledge updates in Family Medicine practice. While conducted in a single FHU, the intervention’s multidimensional approach holds the potential for broader applicability. Conclusion In the future, healthcare teams should continue to reflect on achieved results, maintain knowledge, and empower patients in contraceptive method choices. The study contributes to improved care quality and highlights the positive impact on medical practice and patient outcomes. |
format | Online Article Text |
id | pubmed-10590168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-105901682023-10-22 Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study Novais, Catarina Santos, Joaquim Alves, Claúdia Mendonça, Ema Salgado, João Lopes, Diogo Cruz, Ana Margarida Cureus Family/General Practice Introduction Family planning is fundamental in primary care (PC), and informed counseling helps to guide contraceptive choices. Combined hormonal contraceptives (CHC) pose cardiovascular risks, particularly when combined with smoking. According to the World Health Organization, the recommended global clinical decision is to refrain from employing CHC in female smokers aged 35 or older. This study aimed to improve contraception prescription for female smokers aged 35-54 in PC. Methods This study was conducted in a Portuguese Family Health Unit (FHU) from October 2021 to August 2022, and it followed the Standards for Quality Improvement Reporting Excellence (SQUIRE 2.0) guidelines and the Plan-Do-Study-Act approach. Female smokers aged 35-54 were included and evaluated in three moments: baseline evaluation (October 2021), intermediate evaluation (February 2022), and post-intervention evaluation (August 2022). Interventions involved educating medical staff, creating patient awareness campaigns, and evaluating contraceptive methods. The established quality-defining goal was to decrease the prevalence of female smokers aged 35 or above using CHC to ≤5%. Results CHC prevalence among smoking women aged 35-54 decreased from 16.4% to 8.5% after nine months of the initial intervention. There was an increase in progestogen-only methods usage over time, from 25.7% to 34.0%. Discussion Despite not fully achieving the predefined goal, interventions led to a substantial reduction of CHC use among smoking women aged 35-54. Collaborative efforts between healthcare professionals and patients played a pivotal role in optimizing care and reducing cardiovascular risk. This study underscores the importance of continuous quality improvement, collaborative interventions, and knowledge updates in Family Medicine practice. While conducted in a single FHU, the intervention’s multidimensional approach holds the potential for broader applicability. Conclusion In the future, healthcare teams should continue to reflect on achieved results, maintain knowledge, and empower patients in contraceptive method choices. The study contributes to improved care quality and highlights the positive impact on medical practice and patient outcomes. Cureus 2023-09-21 /pmc/articles/PMC10590168/ /pubmed/37868398 http://dx.doi.org/10.7759/cureus.45701 Text en Copyright © 2023, Novais et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Family/General Practice Novais, Catarina Santos, Joaquim Alves, Claúdia Mendonça, Ema Salgado, João Lopes, Diogo Cruz, Ana Margarida Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title | Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title_full | Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title_fullStr | Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title_full_unstemmed | Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title_short | Optimizing Contraceptive Prescription in Smoking Women: A Quality Improvement Study |
title_sort | optimizing contraceptive prescription in smoking women: a quality improvement study |
topic | Family/General Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590168/ https://www.ncbi.nlm.nih.gov/pubmed/37868398 http://dx.doi.org/10.7759/cureus.45701 |
work_keys_str_mv | AT novaiscatarina optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT santosjoaquim optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT alvesclaudia optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT mendoncaema optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT salgadojoao optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT lopesdiogo optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy AT cruzanamargarida optimizingcontraceptiveprescriptioninsmokingwomenaqualityimprovementstudy |